Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas (Q39891040)

https://doi.org/10.1016/j.canlet.2013.02.026

15 September 2017

1 reference

29 December 2023

http://retractionwatch.com/2013/03/04/retraction-count-for-gynecologic-cancer-researcher-takai-grows-to-seven/

title

Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas (English)

1 reference

15 September 2017

Noriyuki Takai

1 reference

15 September 2017

Tami Ueda

1 reference

15 September 2017

Kaei Nasu

1 reference

15 September 2017

Satoko Yamashita

1 reference

15 September 2017

Mayo Toyofuku

1 reference

15 September 2017

Hisashi Narahara

1 reference

15 September 2017

language of work or name

English

0 references

publication date

24 January 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

277

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

235-243

1 reference

Activation of Ca2+/calmodulin-dependent protein kinase II is involved in hyperosmotic induction of the human taurine transporter

15 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Regulation of cell cycle progression by calcium/calmodulin-dependent pathways

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Estrogens and cell-cycle regulation in breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Ca2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Expression of c-Ets1 is associated with malignant potential in endometrial carcinoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Increased surface phosphatidylserine is an early marker of neuronal apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Redox regulation of the calcium/calmodulin-dependent protein kinases.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Human Ca2+/calmodulin-dependent protein kinase kinase beta gene encodes multiple isoforms that display distinct kinase activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Targeting of calcium/calmodulin-dependent protein kinase II.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Cyclins and cell cycle checkpoints

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Characterization of the mechanism of regulation of Ca2+/ calmodulin-dependent protein kinase I by calmodulin and by Ca2+/calmodulin-dependent protein kinase kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Cations and calmodulin in normal and neoplastic cell growth regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Minireview: Cyclin D1: normal and abnormal functions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced Ikappa B phosphorylation in human T lymphocytes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Identification of novel human tumor cell-specific CaMK-II variants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

G1 phase progression: cycling on cue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.CANLET.2008.12.018

Identifiers

DOI

10.1016/J.CANLET.2008.12.018

1 reference

15 September 2017

1 reference